Trial · NCT05001737
Trial comparisons12
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 12 of 12
Download this page as JSON| Comparison | Source |
|---|---|
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Laboratory Parameters | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Study Interruption Due to Safety Reasons | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Withdrawal From the Study Due to Lack of Response | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Adverse Events (AEs) (Serious and Non-serious). | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Survival | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): MAS Recurrence at Anytime After Achievement of CR | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Proportion of Subjects With Overall Response as Defined by CR or Partial Response (PR) | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Proportion of Subjects With Complete Response (CR) at Week 8 After First Administration of Emapalumab | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Number of Patients With GCs Tapering to ≤1mg/kg/Day of PDN Equivalent at Any Time Until End of Study (EOS). | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): deaths from any cause | Trial comparisons |
Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): Number of Patients With Glucocorticoids (GC)s Tapering to a Dose Below 50% of Prednisolone (PDN) Equivalent at the Time of Emapalumab Start or to the Same (or Lower) Dose Being Administered Before the Occurrence of MAS Whichever Occurs First | Trial comparisons |
| Cohort 1 (sJIA and AOSD) vs Cohort 2 (SLE): serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05001737/comparisons